Cargando…
Update on Adjuvant Chemotherapy for Early Breast Cancer
Breast cancer is the second most common cancer in women worldwide. Although most women are diagnosed with early breast cancer, a substantial number recur due to persistent micro-metastatic disease. Systemic adjuvant chemotherapy improves outcomes and has advanced from first-generation regimens to mo...
Autores principales: | Rampurwala, Murtuza M, Rocque, Gabrielle B, Burkard, Mark E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197909/ https://www.ncbi.nlm.nih.gov/pubmed/25336961 http://dx.doi.org/10.4137/BCBCR.S9454 |
Ejemplares similares
-
Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer
por: Hajjar, Ali, et al.
Publicado: (2019) -
Updated Adjuvant Chemotherapy for Gastric Cancer
por: Takayama, Toshizo, et al.
Publicado: (2023) -
Adjuvant chemotherapy for early breast cancer.
por: Henderson, I. C.
Publicado: (1990) -
Update of Adjuvant Chemotherapy for Resected Gastric Cancer
por: Oh, Sang Cheul
Publicado: (2012) -
Progress in adjuvant chemotherapy for breast cancer: an overview
por: Anampa, Jesus, et al.
Publicado: (2015)